10/31/2025
New advances are changing how IgG4-related disease (IgG4-RD) is treated — and what patients and clinicians can expect in the years ahead.
🎥 In this new IgG4ward! PeachJAM Series video, Dr. Arezou Khosroshahi and Dr. John Stone explore the science and the hope behind new treatment options — from traditional steroid therapy to targeted biologics like rituximab and inebilizumab, the first FDA-approved medication for IgG4-RD.
Watch the full talk and explore key highlights on our blog: https://tinyurl.com/yzt57hup